ArticleBone marrow transplantation2019

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Jakob R Passweg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.